<DOC>
	<DOCNO>NCT02770950</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety Zushima plaster patient knee osteoarthrosis post-marketing .</brief_summary>
	<brief_title>Zushima Plaster Treating Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Ages 4075 ; Unilateral bilateral knee OA , confirm radiographically ; Patients take oral NSAIDs prior breakthrough period permit ; VAS pain score 20mm . Knee swollen hot ; Allergic ingredient Girald Daphne Bark Plaster ( Girald Daphne Bark , Lithargite , Linseed oil , Red lead ) ; Congestive Heart Failure Edema ; Advanced renal disease ; Knee joint skin burst skin disease allergy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Knee Osteoarthritis</keyword>
</DOC>